Introduction
The heart and gut are electromechanical organs, both designed to move content efficiently and effectively. Disruption of this process results in disease. Chronic intestinal pseudo-obstruction (CIPO) can be viewed as an insufficiency of the 'intestinal pump' similar to chronic heart failure. The lack of either coordination or propulsive forces generated by the gastrointestinal smooth muscle impairs intestinal propulsion of luminal contents. As a result, the clinical picture is characterized by recurrent episodes of nausea, bloating, and vomiting that are clinically undistinguishable from true mechanical obstruction [1] [2] [3] . CIPO is still poorly understood.
It appears to be a heterogeneous disease with different underlying etiologies presenting with a similar clinical picture. Alteration in the structure or function of the key cell types involved in the control of gastrointestinal motility, including smooth muscle cells, interstitial cells of Cajal (ICCs), as well as intrinsic and extrinsic nerves, can elicit the severe motor derangement observed in patients with CIPO [4, 5] . Neuro-ICC-muscular abnormalities in CIPO may be either secondary to a number of recognized diseases [3, [5] [6] [7] or idiopathic [1] [2] [3] [4] 6] .
Here, we describe the case of a young male patient with a manometrically and histologically proven myopathic CIPO who developed symptomatic tachy-brady arrhythmia diagnosed as sick sinus syndrome (SSS). Notably, the patient had anticonductive tissue autoantibodies suggesting a possible autoimmune-mediated dysrhythmia.
This unusual coincidence between CIPO and SSS and the possible pathogenetic role of autoimmunity suggests that further studies evaluating whether a link exists between intestinal and cardiac abnormal rhythmicity are warranted.
Case report
A 26-year-old male patient was referred for a 4-year history of progressively severe digestive symptoms including diarrhea, postprandial vomiting, abdominal pain, distension, and weight loss. His family history was negative for major genetic and acquired diseases. The clinical picture was complicated by recurrent intestinal subocclusive episodes. Repeated endoscopic and radiologic tests failed to identify any organic lesion. Explorative laparoscopies performed in other hospitals did not identify a cause or show any evidence for obstruction. Following referral, a diagnosis of CIPO was established [2, 3, 8, 9] . A stationary small bowel manometry showed normally propagated interdigestive activity fronts, suggesting an intact neuronal system [2, 3, 5, 9] . However, the contractile strength was reduced with decreased amplitude, suggestive of an underlying myogenic disorder ( Supplementary Fig. 1 ) [9] [10] [11] . During a decompressive ileostomy, full-thickness biopsies of the ileum were obtained and analyzed by conventional histopathology and immunohistochemistry [12] . Marked abnormalities of the smooth muscle architecture characterized by degeneration and vacuolization of smooth muscle cells, along with fibrosis, were identified by hematoxylin and eosin and Masson's trichrome staining. The findings were confirmed using antibodies to a-smooth muscle actin and desmin [13] [14] [15] (Fig. 1 ). Antibodies targeting pan-neuronal markers, such as neuron-specific enolase and protein gene product 9.5, identified an apparently normal enteric innervation. Also, glial cells (S-100b) and ICC (Kit) were labeled by their respective antibodies and showed an apparently normal immunoreactive pattern. Following the gastrointestinal work-up, the patient was discharged and total parenteral nutrition was initiated after the patient failed tube feedings.
After a few months, the patient was admitted to a Cardiology Unit because of tachy-brady arrhythmia episodes manifesting with recurrent syncopes (Fig. 2) . A cardiac ultrasound was normal as well as skeletal muscle and endomyocardial biopsies, performed to rule out a systemic disease or myocarditis. An ECG Holter test showed an SSS that required a bicameral pacemaker implantation (DDDR; Medtronic Adapta, Minneapolis, Minnesota, USA). b-blocker treatment was initiated, followed by a dose increase: metoprolol 25 mg twice daily-carvedilol 3.125 mg twice daily-6.25 mg twice daily, subsequently changed to full-dose atenolol 50 mg twice daily ( Fig. 3 ). Despite this treatment, the patient experienced long-lasting supraventricular tachyarrhythmia ( Supplementary Fig. 2 ). In an attempt to investigate the origin of the cardiologic impairment, autoantibodies directed against the cardiac conductive tissue were tested (see below). Because of the strong positivity to such autoantibodies, the patient was treated with steroids. He was started on methylprednisolone 1 mg/kg, tapered down to a maintenance dose (8 mg/day) over a period of 24 months. The patient showed a progressive improvement in tachyarrhythmia episodes as documented by repeated Holter monitor tests ( Supplementary Fig. 2 ). Although the patient showed a significant improvement in the cardiac symptoms, the severe gut dysfunction remained unchanged, continuing to require home parenteral nutrition.
Materials and methods
The patient's serum was tested for cardiac conducting tissue autoantibodies (CCTA) using an indirect immunofluorescence technique. Serum samples obtained at different stages of the patient's clinical history (in relation to immunosuppressive treatment) were tested at the initial dilution of 1 : 10 and, when positive, were (a) Fast supraventricular tachycardia, with palpitations and occasional dizziness. Electrical cardioversion was effective in restoring episodes of sinus rhythm (1). Note frequent premature atrial contractions (*) and short runs of supraventricular tachycardia, occasionally in conjunction with Wenckebach-type atrioventricular conduction (^); junctional escape beats were also observed (''). (b) 'Reverse' atrial flutter. (c) 'Early' premature atrial contractions with 'P' on 'T' phenomenon (1); Wenckebach-type atrioventricular conduction (*); aberrance on the second conducted atrial beat (''); and a couple of premature ventricular contractions (^). (d) 'Blocked' sinus beat (1) at the end of an atrial ectopic activity (*), with the occurrence of a 2.9 s pause.
titrated up to the endpoint. The secondary antibody applied was an affinity purified polyclonal rabbit antihuman IgG (Dako, Glostrup, Denmark). Tissue substrates used were ox myocardium and conducting tissues including sinus atrial node, atrioventricular node, and the right side of the ventricular septum, according to a previously published method [16, 17] . Ox tissues were snap frozen in isopentane precooled with an acetone-solid CO 2 mixture and kept at -801C until cryostat sections were cut. Ox tissues were chosen as in ungulates the Purkinje fibers are larger than cardiac fibers and readily recognizable on microscopy, and because earlier studies also used ox heart [16, 17] . We also tested the patient's serum for other autoantibodies, that is, antienterocyte, antineuronal, antinuclear, and antismooth muscle antibodies. These were assessed using monkey jejunum cryostat sections (used routinely to screen for antienterocyte antibodies), rat ileum and colon cryostat sections (used to test antienteric nervous system antibodies), and, finally, rat kidney and liver (used to determine antismooth muscle and antinuclear antibodies). Control sera obtained from healthy blood donors were tested simultaneously with the patient's serum using the same technique.
Results
CCTA positivity was characterized by bright fluorescence of the sinoatrial node, atrioventricular node, and bundle branches including Purkinje fibers running through the ventricular septum with no staining of myocardial tissue (Fig. 3a-c) . The immunolabeling appeared to be cytoplasmic. Sera obtained before, during, and after immunosuppressive treatment (methylprednisolone 60 mg/day tapered down over a period of 24 months) did not show major differences in terms of the immunofluorescence pattern and CCTA antibody titer (i.e. bright staining was observed up to a dilution of 1 : 200). Apart from CCTA, the patient's serum did not contain other autoantibodies (listed in the Materials and methods section). Control sera were consistently negative for CCTA ( Fig. 3e ). Histochemical analysis with trichrome staining confirmed the location of the areas where conducting tissues were obtained (Fig. 3d ).
Discussion
This case represents a coincidental association between CIPO of myogenic origin and a life-threatening cardiologic impairment, that is, tachy-brady arrhythmia or SSS. In addition, CCTA were detected in the patient's serum, likely reflecting an autoimmune insult occurring in the conductive cardiac system.
Very little is known about the association between CIPO and heart disease, but emerging evidence suggests a link. Previous studies showed cardiac changes, such as membranous interventricular septal defect, and trivial pulmonic valve stenosis, in two members of a Turkish family with a genetic form of CIPO. Notably, no electrophysiological abnormalities were documented in these two patients [18, 19] . Moreover, patients with mutations in Nav1.5 showed both cardiac arrthymias and gastrointestinal symptoms [20, 21] . In addition, a mutation in the TCAP gene, encoding the small protein telethonin expressed both in the heart and in the gastrointestinal tract, has been documented in a 42year-old male patient with CIPO. The possibility that telethonin mutation can alter Nav1.5 function represents a molecular substrate for a common involvement of gastrointestinal and cardiac tissues [22] .
In our case, there was no evidence of familial cluster and therefore the patient was considered as affected by a sporadic CIPO with an unusual association between CIPO and cardiac abnormalities, predominantly characterized by conductive tissue defects leading to symptomatic tachybrady arrhythmia/SSS. The latter condition, which is usually diagnosed in elderly patients, was further investigated by an endocardial biopsy. As a distinctive feature from elderly patients with arrhythmia/SSS, the cardiac tissue analysis in our case did not show major fibrotic (scar-like) degeneration or inflammatory infiltrate of the cardiac muscle. This and a normal ejection fraction make it highly unlikely that cardiac insufficiency resulted in myogenic CIPO. A link between CIPO and cardiac conductive system impairment through autoantibodies is possible, although a firm cause-effect relationship cannot be established between the two conditions from this case report.
In our immunofluorescence experiments, the CCTA recognized different portions of the ox cardiac conductive tissue (i.e. sinoatrial node, atrioventricular node, and bundle branches including Purkinje fibers). The exact molecular targets of CCTA as well as origin remain unknown. The immunofluorescent pattern of CCTA was characterized by a bright, cytoplasmic staining of the cardiac conductive tissue. A possibility is that CCTA in this case may have arisen secondary to the profound enteric muscular abnormalities observed in this case. The enteric smooth muscle damage might have exposed/released structural proteins, triggering an inappropriate immune response [23] .
Another interesting question arising from this case report is whether CCTA may have played a pathogenetic role in the cardiac dysrhythmias of this patient. In fact, Maisch et al. [24] reported autoantibodies similar to CCTA and established a 10-fold risk of developing SSS in patients carrying antisinus node antibodies and a 2.2-fold risk of acquiring atrioventricular blocks in patients with autoantibodies to atrioventricular node. Furthermore, CCTA have been identified in patients with autoimmunemediated connective tissue disorders with cardiac involvement, such as scleroderma and rheumatoid arthritis [16, 17] . However, these studies, like our case report, did not clarify whether CCTA actively contributed to arrhythmias or were an immunological epiphenomenon. In favor of the first possibility is the clinical evidence that the patient's cardiac conditions improved significantly after steroid treatment (currently, he is still being treated with 8 mg of methylprednisolone), whereas the second possibility might be supported by the lack of a reduced CCTA titer following the long-term steroid treatment.
However, it is worth noting that persistence of detectable autoantibodies following steroid treatment can occur in other autoimmune diseases, such as antinuclear and antismooth muscle antibodies in patients with autoimmune hepatitis [25] . Representative photomicrographs showing cardiac conducting tissue autoantibodies of the investigated patient. Compared with the control (e), the patient's serum containing cardiac conducting tissue autoantibodies led to an intense immunolabeling of the sinus atrial node (a), atrioventricular node (b), and right side Purkinje fibers (c). This immunolabeling did not vary before, during, and after treatment with corticosteroids. Identification of the conducting tissues was confirmed by trichrome Masson staining of the right side Purkinje fibers (d). Original magnification: Â 250 for each image.
Conclusion
This case showed a sporadic form of myogenic (degenerative myopathy) CIPO together with a life-threatening arrhythmia (mainly SSS). The rarity of this coincidental association was increased by the finding of circulating CCTA. The origin of CCTA as well as their potential pathogenetic role in driving cardiac arrhythmias and the possibility of a link between intestinal and cardiac abnormal rhythmicity will require further study.
